Cough Remedies Market by Drug Type (Prescription, Non-Prescription or OTC); by Product Type (Oral Syrup, Tablets/Pills, Others); by End User (Hospital Pharmacies, Retail Pharmacies, E-Commerce/Online Pharmacies, Others); by Medical Practices (Homeopathy, Allopathic, Ayurveda, Others); By Severity (Chronic Causes, Acute Causes) by Regional Outlook (U.S., Rest of North America) – North America Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018 - 2026’

Report ID :AMI-63 | Category : Therapeutic Area | Published Date :June, 2018 | Pages : 213 | Format :PDF
Buy Now!

Industry Trends

Cough is a very common symptom in humans and is an important defensive and protective act whose action secures the removal of mucus, noxious substances and mucus from throat. According to the National Medical Survey, cough was most common complaint in the U.S. for which patients sought medical attention. Nearly all conditions affecting the respiratory system and other extra pulmonary conditions causes cough. However, to the physician it is most important to identify the most serious conditions which need prompt treatment. The cough remedies market, in terms of revenue, was valued at US$ 4.13 Bn in 2017 and is expected to reach US$ 4.85 Bn by 2022.

North America Cough Remedies Market, By Medical Practices, 2017 and 2022 (USD Billion)

Cough Remedies Market

According to the medical practices, North America cough remedies market is classified as homeopathy, allopathic, ayurveda and others. By medical practices, allopathic accounted for major share followed by ayurveda. The reason behind the usage of the allopathic cough remedies is the effectiveness during an emergency. Owing to the fast results, these medicines are considered as ideal for such treatment purpose. Treatment of cough through allopathy is beneficial as it helps to manage illness in short and long term.

There are several cases of Acute bronchitis in the North America region each year and about 5% of adults suffer from acute bronchitis each year. An estimated 90% of these seek medical advice for the same. In the U.S., acute bronchitis is one of the common illness among patients. The prevalence of acute bronchitis is fueling the cough remedies market.

Besides benefits of cough medicines, there are several side effects too associated with it. Some of the common side effects of these medicines include diarrhea, headache, nausea, constipation and drowsiness. These side effects can prevent patients from buying these medicines, which can critically impact the market growth over the forecast period.

The research and development in the cough medicines to reduce the serious side effects can help to provide opportunities in future. Overdose of cough syrup can cause some serious side effects such as blurred vision, drowsiness, vomiting and slowed breathing amongst others.

Cough Remedies Market, by Product Type

In North America market, oral syrup is expected to dominate the segment during the forecast year. Oral syrup is recommended for children younger than 6 years. Oral syrup forms a protective layer over a throat which may soothe a sore throat and ease cough. Glycerol is major component of cough syrups owing to the properties such as sweetness, lubrication and demulcency. Cough syrup has fast absorbing properties compared to tablets, therefore the use of oral syrup has more demand compared to tablets.

Competitive Market Share

The North America cough remedies market report provides both, qualitative and quantitative research of the market, as well as it helps to gain important insights of current and future market and trending technologies adopted by the key players. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisitions(M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their manufacturing base, competitors, product type, application and specification, pricing, and gross margin.

Some of the key participants of North America cough remedies market Procter & Gamble Co., Johnson & Johnson, Bayer Corporation, Reckitt Benckiser Group, Wyeth Consumer Healthcare, Astrazeneca, Taro Pharmaceuticals USA, Inc., P.J. Noyes Company, Inc., Sun Pharmaceutical and Mondel?z International, Inc. amongst others.

Cough Remedies Industry Background

Cough Remedies Market Cough Remedies Market

1.    Introduction

1.1.   Market Scope

1.2.   Market Segmentation

1.3.   Methodology

1.4.   Assumptions

2.    Cough Remedies Market Snapshot

3.    Executive Summary: Cough Remedies Market

4.    Qualitative Analysis: Cough Remedies Market

4.1.   Introduction

4.1.1.   Product Definition

4.1.2.   Industry Development

4.2.   Market Dynamics

4.2.1.   Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.3.   Trends in Cough Remedies Market

5.    North America Cough Remedies Market Analysis and Forecasts, 2018 – 2026

5.1.   Overview

5.1.1.   North America Cough Remedies Market Revenue (US$ Mn) and Forecasts

5.2.   North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By  Drug Type

5.2.1.   Prescription

5.2.1.1.    Definition

5.2.1.2.    Market Penetration

5.2.1.3.    Market Revenue Expected to Increase by 2026

5.2.1.4.    Compound Annual Growth Rate (CAGR)

5.2.2.   Non-Prescription or OTC

5.2.2.1.    Definition

5.2.2.2.    Market Penetration

5.2.2.3.    Market Revenue Expected to Increase by 2026

5.2.2.4.    Compound Annual Growth Rate (CAGR)

5.3.   Key Segment for Channeling Investments

5.3.1.   By  Drug Type

6.    North America Cough Remedies Market Analysis and Forecasts, 2018 – 2026

6.1.   Overview

6.2.   North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Product Type

6.2.1.   Oral Syrup

6.2.1.1.    Definition

6.2.1.2.    Market Penetration

6.2.1.3.    Market Revenue Expected to Increase by 2026

6.2.1.4.    Compound Annual Growth Rate (CAGR)

6.2.2.   Tablets/Pills

6.2.2.1.    Definition

6.2.2.2.    Market Penetration

6.2.2.3.    Market Revenue Expected to Increase by 2026

6.2.2.4.    Compound Annual Growth Rate (CAGR)

6.2.3.   Others

6.2.3.1.    Definition

6.2.3.2.    Market Penetration

6.2.3.3.    Market Revenue Expected to Increase by 2026

6.2.3.4.    Compound Annual Growth Rate (CAGR)

6.3.   Key Segment for Channeling Investments

6.3.1.   By Product Type

7.    North America Cough Remedies Market Analysis and Forecasts, 2018 – 2026

7.1.   Overview

7.2.   North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By End User

7.2.1.   Hospital Pharmacies

7.2.1.1.    Definition

7.2.1.2.    Market Penetration

7.2.1.3.    Market Revenue Expected to Increase by 2026

7.2.1.4.    Compound Annual Growth Rate (CAGR)

7.2.2.   Retail Pharmacies

7.2.2.1.    Definition

7.2.2.2.    Market Penetration

7.2.2.3.    Market Revenue Expected to Increase by 2026

7.2.2.4.    Compound Annual Growth Rate (CAGR)

7.2.3.   E-Commerce/Online Pharmacies

7.2.3.1.    Definition

7.2.3.2.    Market Penetration

7.2.3.3.    Market Revenue Expected to Increase by 2026

7.2.3.4.    Compound Annual Growth Rate (CAGR)

7.2.4.   Others

7.2.4.1.    Definition

7.2.4.2.    Market Penetration

7.2.4.3.    Market Revenue Expected to Increase by 2026

7.2.4.4.    Compound Annual Growth Rate (CAGR)

7.3.   Key Segment for Channeling Investments

7.3.1.   By End User

8.    North America Cough Remedies Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.2.   North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Medical Practices

8.2.1.   Homeopathy

8.2.1.1.    Definition

8.2.1.2.    Market Penetration

8.2.1.3.    Market Revenue Expected to Increase by 2026

8.2.1.4.    Compound Annual Growth Rate (CAGR)

8.2.2.   Allopathic

8.2.2.1.    Definition

8.2.2.2.    Market Penetration

8.2.2.3.    Market Revenue Expected to Increase by 2026

8.2.2.4.    Compound Annual Growth Rate (CAGR)

8.2.3.   Ayurveda

8.2.3.1.    Definition

8.2.3.2.    Market Penetration

8.2.3.3.    Market Revenue Expected to Increase by 2026

8.2.3.4.    Compound Annual Growth Rate (CAGR)

8.2.4.   Others

8.2.4.1.    Definition

8.2.4.2.    Market Penetration

8.2.4.3.    Market Revenue Expected to Increase by 2026

8.2.4.4.    Compound Annual Growth Rate (CAGR)

8.3.   Key Segment for Channeling Investments

8.3.1.   By Medical Practices

9.    North America Cough Remedies Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.2.   North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Severity

9.2.1.   Chronic Causes (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Allergies, Bronchitis, Asthma, Others)

9.2.1.1.    Allergies

9.2.1.2.    Bronchitis

9.2.1.3.    Asthma

9.2.1.4.    Others

9.2.2.   Acute Causes (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Common Cold, Influenza, Pneumonia, Whooping Cough, Others)

9.2.2.1.    Common Cold

9.2.2.2.    Influenza

9.2.2.3.    Pneumonia

9.2.2.4.    Whooping Cough

9.2.2.5.    Others

9.3.   Key Segment for Channeling Investments

9.3.1.   By Severity

10. North America Cough Remedies Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.2. North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Country

10.2.1. U.S.

10.2.1.1.  U.S. Cough Remedies Market Revenue (US$ Mn) and Forecasts, By  Drug Type

10.2.1.1.1.  Prescription

10.2.1.1.2.  Non-Prescription or OTC

10.2.1.2.  U.S. Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Product Type

10.2.1.2.1.  Oral Syrup

10.2.1.2.2.  Tablets/Pills

10.2.1.2.3.  Others

10.2.1.3.  U.S. Cough Remedies Market Revenue (US$ Mn) and Forecasts, By End User

10.2.1.3.1.  Hospital Pharmacies

10.2.1.3.2.  Retail Pharmacies

10.2.1.3.3.  E-Commerce/Online Pharmacies

10.2.1.3.4.  Others

10.2.1.4.  U.S. Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Medical Practices

10.2.1.4.1.  Homeopathy

10.2.1.4.2.  Allopathic

10.2.1.4.3.  Ayurveda

10.2.1.4.4.  Others

10.2.1.5.  U.S. Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Severity

10.2.1.5.1.  Chronic Causes

10.2.1.5.1.1.                Allergies

10.2.1.5.1.2.                Bronchitis

10.2.1.5.1.3.                Asthma

10.2.1.5.1.4.                Others

10.2.1.5.2.  Acute Causes

10.2.1.5.2.1.                Common Cold

10.2.1.5.2.2.                Influenza

10.2.1.5.2.3.                Pneumonia

10.2.1.5.2.4.                Whooping Cough

10.2.1.5.2.5.                Others

10.2.2. Rest of North America

10.2.2.1.  Rest of North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By  Drug Type

10.2.2.1.1.  Prescription

10.2.2.1.2.  Non-Prescription or OTC

10.2.2.2.  Rest of North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Product Type

10.2.2.2.1.  Oral Syrup

10.2.2.2.2.  Tablets/Pills

10.2.2.2.3.  Others

10.2.2.3.  Rest of North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By End User

10.2.2.3.1.  Hospital Pharmacies

10.2.2.3.2.  Retail Pharmacies

10.2.2.3.3.  E-Commerce/Online Pharmacies

10.2.2.3.4.  Others

10.2.2.4.  Rest of North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Medical Practices

10.2.2.4.1.  Homeopathy

10.2.2.4.2.  Allopathic

10.2.2.4.3.  Ayurveda

10.2.2.4.4.  Others

10.2.2.5.  Rest of North America Cough Remedies Market Revenue (US$ Mn) and Forecasts, By Severity

10.2.2.5.1.  Chronic Causes

10.2.2.5.1.1.                Allergies

10.2.2.5.1.2.                Bronchitis

10.2.2.5.1.3.                Asthma

10.2.2.5.1.4.                Others

10.2.2.5.2.  Acute Causes

10.2.2.5.2.1.                Common Cold

10.2.2.5.2.2.                Influenza

10.2.2.5.2.3.                Pneumonia

10.2.2.5.2.4.                Whooping Cough

10.2.2.5.2.5.                Others

10.3. Key Segment for Channeling Investments

10.3.1. By Country

11. Competitive Benchmarking

11.1. Player Positioning Analysis

11.2. North America Presence and Growth Strategies

12. Player Profiles

12.1. Procter & Gamble Co.

12.1.1. Company Details

12.1.2. Company Overview

12.1.3. Product Offerings

12.1.4. Key Developments

12.1.5. Financial Analysis

12.1.6. SWOT Analysis

12.1.7. Business Strategies

12.2. Johnson & Johnson

12.2.1. Company Details

12.2.2. Company Overview

12.2.3. Product Offerings

12.2.4. Key Developments

12.2.5. Financial Analysis

12.2.6. SWOT Analysis

12.2.7. Business Strategies

12.3. Bayer Corporation

12.3.1. Company Details

12.3.2. Company Overview

12.3.3. Product Offerings

12.3.4. Key Developments

12.3.5. Financial Analysis

12.3.6. SWOT Analysis

12.3.7. Business Strategies

12.4. Wyeth Consumer Healthcare

12.4.1. Company Details

12.4.2. Company Overview

12.4.3. Product Offerings

12.4.4. Key Developments

12.4.5. Financial Analysis

12.4.6. SWOT Analysis

12.4.7. Business Strategies

12.5. Reckitt Benckiser Group

12.5.1. Company Details

12.5.2. Company Overview

12.5.3. Product Offerings

12.5.4. Key Developments

12.5.5. Financial Analysis

12.5.6. SWOT Analysis

12.5.7. Business Strategies

12.6. Astrazeneca

12.6.1. Company Details

12.6.2. Company Overview

12.6.3. Product Offerings

12.6.4. Key Developments

12.6.5. Financial Analysis

12.6.6. SWOT Analysis

12.6.7. Business Strategies

12.7. Taro Pharmaceuticals USA, Inc.

12.7.1. Company Details

12.7.2. Company Overview

12.7.3. Product Offerings

12.7.4. Key Developments

12.7.5. Financial Analysis

12.7.6. SWOT Analysis

12.7.7. Business Strategies

12.8. P.J. Noyes Company, Inc.

12.8.1. Company Details

12.8.2. Company Overview

12.8.3. Product Offerings

12.8.4. Key Developments

12.8.5. Financial Analysis

12.8.6. SWOT Analysis

12.8.7. Business Strategies

12.9. Sun Pharmaceutical

12.9.1. Company Details

12.9.2. Company Overview

12.9.3. Product Offerings

12.9.4. Key Developments

12.9.5. Financial Analysis

12.9.6. SWOT Analysis

12.9.7. Business Strategies

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.   

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

 

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 204

    Backtrace:

    File: /home/absolute/public_html/application/views/pages/reportpage.php
    Line: 204
    Function: _error_handler

    File: /home/absolute/public_html/application/controllers/Report.php
    Line: 153
    Function: view

    File: /home/absolute/public_html/index.php
    Line: 315
    Function: require_once